Current management of neuroblastoma and future direction

Title
Current management of neuroblastoma and future direction
Authors
Keywords
ALK, Disialoganglioside (GD2), Immunotherapy, MYCN, Radiotherapy, TrkB
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 138, Issue -, Pages 38-43
Publisher
Elsevier BV
Online
2019-04-01
DOI
10.1016/j.critrevonc.2019.03.013

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search